Anti-RNP antibodies are considered products of long-lived plasma cells, and their levels tend to remain stable over time, resembling antibody responses to vaccines or persistent pathogens; consequently, they are not typically regarded as markers of disease flares in SLE. This evidence concerns the gene RNPC3 and systemic lupus erythematosus.